Cresset Asset Management, LLC

Position in GERN — Geron Corp

CIK 1761013 Chicago, IL

Position in GERN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$255,624

-$34,127 QoQ

Shares Held

199,707

+2.7% QoQ

Ownership

0.031%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#91

of 259 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cresset Asset Management, LLC holds $108,155,066 across 44 Biotechnology names. GERN ranks #26 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	736,708	$52,048,420
2	HALO	Halozyme Therapeutics, Inc.	260,937	$20,423,538
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,926	$3,937,081
4	EXEL	Exelixis, Inc.	70,918	$3,858,648
5	HRMY	Harmony Biosciences Holdings, Inc.	102,479	$3,731,260
6	TVTX	Travere Therapeutics, Inc.	35,433	$2,012,948
7	MRNA	Moderna, Inc.	28,359	$1,985,980
8	PVLA	Palvella Therapeutics, Inc.	11,629	$1,777,143

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$255,624	199,707	+2.7%	Shares	Sole	2026-08-14
2026-03-31	$289,751	194,464	+3.1%	Shares	Sole	2026-05-15
2025-12-31	$248,880	188,546	+3.1%	Shares	Sole	2026-02-17
2025-09-30	$250,496	182,844	+3.1%	Shares	Sole	2026-01-22
2025-06-30	$249,998	177,304	+2.6%	Shares	Sole	2026-01-22
2025-03-31	$274,885	172,884	+1.6%	Shares	Sole	2025-05-13
2024-12-31	$602,454	170,185	+0.6%	Shares	Sole	2025-02-14
2024-09-30	$768,168	169,200	+1.6%	Shares	Defined	2024-11-14
2024-06-30	$705,968	166,502	+1.5%	Shares	Defined	2024-08-14
2024-03-31	$541,332	164,040	+2.1%	Shares	Sole	2024-05-15
2023-12-31	$338,937	160,634	+2.2%	Shares	Sole	2024-02-14
2023-09-30	$333,357	157,244	+1.4%	Shares	Sole	2023-11-14
2023-06-30	$497,566	155,005	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.